Czech National Bank Acquires 8,435 Shares of Ventas, Inc. $VTR

Czech National Bank grew its stake in shares of Ventas, Inc. (NYSE:VTR) by 7.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 123,861 shares of the real estate investment trust’s stock after acquiring an additional 8,435 shares during the period. Czech National Bank’s holdings in Ventas were worth $9,584,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. NewEdge Advisors LLC lifted its holdings in Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC boosted its stake in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP grew its holdings in Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares in the last quarter. Focus Partners Wealth grew its holdings in Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after buying an additional 12,233 shares in the last quarter. Finally, Cetera Investment Advisers increased its position in shares of Ventas by 3.4% during the second quarter. Cetera Investment Advisers now owns 36,918 shares of the real estate investment trust’s stock valued at $2,331,000 after buying an additional 1,209 shares during the period. 94.18% of the stock is owned by institutional investors.

Ventas Stock Performance

NYSE:VTR opened at $82.00 on Friday. The stock has a market cap of $38.95 billion, a P/E ratio of 151.86, a PEG ratio of 2.04 and a beta of 0.73. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The business’s 50-day moving average price is $83.04 and its two-hundred day moving average price is $77.46. Ventas, Inc. has a twelve month low of $60.15 and a twelve month high of $88.36.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities analysts predict that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is presently 355.56%.

Insider Transactions at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 86,106 shares of company stock valued at $6,931,397 in the last quarter. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

VTR has been the topic of a number of recent analyst reports. Mizuho increased their price target on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price objective on shares of Ventas in a research note on Monday, February 9th. Scotiabank upped their target price on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Argus set a $88.00 target price on shares of Ventas in a research note on Tuesday, February 10th. Finally, Royal Bank Of Canada raised their price target on shares of Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a report on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average price target of $90.47.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.